David Dai Stock Analyst Profile - UBS Research Coverage - Stocknear

David Dai

Stock Analyst at UBS

(2.41)
# 3206
Out of 5,493 analysts
30
Total ratings
Success rate
Average return

22 Stocks

Name Action PT Current % Upside Ratings Updated
TLX Telix Pharmaceutical...
Maintains: Buy
23 20
9.98 100.4% 1 Sep 23, 2025
SNDX Syndax Pharmaceutica...
Maintains: Buy
37 35
15.68 123.21% 2 Jul 15, 2025
NRIX Nurix Therapeutics
Maintains: Buy
30 26
8.93 191.15% 2 Jul 10, 2025
SMMT Summit Therapeutics
Initiates Coverage On: Buy
30
20.95 43.2% 1 Jul 1, 2025
BPMC Blueprint Medicines
Maintains: Neutral
88 129
n/a n/a 2 Jun 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 2
2.11 -5.21% 2 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 24
5.96 302.68% 2 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
100 100
81.39 22.87% 2 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 14
9.05 54.7% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
24
34.02 -29.45% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
3.37 493.47% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
72
68.89 4.51% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
69
23.23 197.03% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
26.83 86.36% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
37.54 59.83% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
0.84 3233.33% 1 Mar 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
32.68 22.4% 1 Mar 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
1.73 2212.14% 1 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
2.04 2350.98% 1 Nov 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
41 52
34.5 50.72% 1 Mar 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
41
n/a n/a 1 Apr 25, 2017